Medicamente antiobezitate (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Medicamente antiobezitate" in Romanian language version.

refsWebsite

Global rank Romanian rank

22nih.gov

4^th place

20doi.org

2^nd place

3^rd place

5web.archive.org

1^st place

5fda.gov

447^th place

173^rd place

1wikidata.org

43^rd place

2^nd place

1evekeo.com

low place

1archive.org

6^th place

23^rd place

1medscape.com

719^th place

901^st place

1ucl.ac.uk

1,306^th place

823^rd place

1figshare.com

5,893^rd place

984^th place

1poison.org

low place

5,878^th place

1harvard.edu

18^th place

27^th place

1worldcat.org

5^th place

11^th place

1usu.edu

6,479^th place

3,998^th place

archive.org

Pool, Robert (2001). Fat: Fighting the Obesity Epidemic. Oxford, UK: Oxford University Press. ISBN 978-0-19-511853-7.

doi.org

„Drug interventions for the treatment of obesity in children and adolescents”. The Cochrane Database of Systematic Reviews. 11 (11): CD012436. noiembrie 2016. doi:10.1002/14651858.CD012436. PMC 6472619 . PMID 27899001.
„Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians”. Annals of Internal Medicine. 142 (7): 525–531. aprilie 2005. doi:10.7326/0003-4819-142-7-200504050-00011. PMID 15809464.
„The obesity pipeline: current strategies in the development of anti-obesity drugs”. Nature Reviews. Drug Discovery. 5 (11): 919–931. noiembrie 2006. doi:10.1038/nrd2136. PMID 17080028.
„Use and abuse of appetite-suppressant drugs in the treatment of obesity”. Annals of Internal Medicine. 119 (7 Pt 2): 707–713. octombrie 1993. doi:10.7326/0003-4819-119-7_Part_2-199310011-00016. PMID 8363202.
„Effects of GLP-1 on appetite and weight”. Reviews in Endocrine & Metabolic Disorders. 15 (3): 181–187. septembrie 2014. doi:10.1007/s11154-014-9289-5. PMC 4119845 . PMID 24811133.
„Dinitrophenol and bioenergetics: an historical perspective”. Molecular and Cellular Biochemistry. 5 (1–2): 69–77. noiembrie 1974. doi:10.1007/BF01874175. PMID 4610359.
„The return of rainbow diet pills”. American Journal of Public Health. 102 (9): 1676–1686. septembrie 2012. doi:10.2105/AJPH.2012.300655. PMC 3482033 . PMID 22813089.
„Imported fenproporex-based diet pills from Brazil: a report of two cases”. Journal of General Internal Medicine. 24 (3): 430–433. martie 2009. doi:10.1007/s11606-008-0878-4. PMC 2642570 . PMID 19096898.
„Imported compounded diet pill use among Brazilian women immigrants in the United States”. Journal of Immigrant and Minority Health. 11 (3): 229–236. iunie 2009. doi:10.1007/s10903-007-9099-x. PMID 18066718.
„Dependence on the Brazilian diet pill: a case report”. The American Journal on Addictions. 19 (3): 291–292. mai 2010. doi:10.1111/j.1521-0391.2010.00034.x. PMID 20525038.
„Once-Weekly Semaglutide in Adults with Overweight or Obesity”. The New England Journal of Medicine. 384 (11): 989–1002. martie 2021. doi:10.1056/NEJMoa2032183. PMID 33567185.
„Phentermine/topiramate for the treatment of obesity”. The Annals of Pharmacotherapy. 47 (3): 340–349. martie 2013. doi:10.1345/aph.1R501. PMID 23482732.
„Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial”. Lancet. 376 (9741): 595–605. august 2010. doi:10.1016/S0140-6736(10)60888-4. PMID 20673995.
„Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study”. Lancet. 374 (9701): 1606–1616. noiembrie 2009. doi:10.1016/S0140-6736(09)61375-1. PMID 19853906.
„A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss”. Obesity. 27 (2): 205–216. februarie 2019. doi:10.1002/oby.22347. PMC 6587502 . PMID 30421844.
„Drug treatments for obesity: orlistat, sibutramine, and rimonabant”. Lancet. 369 (9555): 71–77. ianuarie 2007. doi:10.1016/S0140-6736(07)60033-6. PMID 17208644.
„Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes”. The New England Journal of Medicine. 385 (6): 503–515. august 2021. doi:10.1056/NEJMoa2107519. PMID 34170647.
„Tirzepatide Once Weekly for the Treatment of Obesity”. The New England Journal of Medicine. 387 (3): 205–216. iulie 2022. doi:10.1056/NEJMoa2206038. PMID 35658024 Verificați valoarea |pmid= (ajutor).
„Current and potential drugs for treatment of obesity”. Endocrine Reviews. 20 (6): 805–875. decembrie 1999. doi:10.1210/edrv.20.6.0383. PMID 10605627.
Siskind, Dan J.; Leung, Janni; Russell, Anthony W.; Wysoczanski, Daniel; Kisely, Steve (15 iunie 2016). Holscher, Christian, ed. „Metformin for clozapine associated obesity: a systematic review and meta-analysis”. PLOS ONE (în engleză). 11 (6): e0156208. Bibcode:2016PLoSO..1156208S. doi:10.1371/journal.pone.0156208. ISSN 1932-6203. PMC 4909277 . PMID 27304831.

evekeo.com

„Evekeo Prescribing Information” (PDF). Arbor Pharmaceuticals LLC. aprilie 2014. pp. 1–2. Arhivat din original (PDF) la 4 martie 2016. Accesat în 11 august 2015.

fda.gov

„www.fda.gov”. Food and Drug Administration. Arhivat din original la 18 ianuarie 2017. Accesat în 16 decembrie 2019.
„FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014”. FDA. 21 iunie 2021. Accesat în 19 iulie 2022.
„Guidance for Industry Developing Products for Weight Management”. Food and Drug Administration. februarie 2007.
Office of the Commissioner (21 iunie 2021). „FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014”. FDA (în engleză). Accesat în 19 iulie 2022.
FDA targets unlawful internet sales of illegal prescription medicines during International Operation Pangea IX

figshare.com

„Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes”. The New England Journal of Medicine. 385 (6): 503–515. august 2021. doi:10.1056/NEJMoa2107519. PMID 34170647.

harvard.edu

adsabs.harvard.edu

Siskind, Dan J.; Leung, Janni; Russell, Anthony W.; Wysoczanski, Daniel; Kisely, Steve (15 iunie 2016). Holscher, Christian, ed. „Metformin for clozapine associated obesity: a systematic review and meta-analysis”. PLOS ONE (în engleză). 11 (6): e0156208. Bibcode:2016PLoSO..1156208S. doi:10.1371/journal.pone.0156208. ISSN 1932-6203. PMC 4909277 . PMID 27304831.

medscape.com

emedicine.medscape.com

„Obesity Medication: Gastrointestinal Agents, Other, CNS Stimulants, Anorexiants, Glucagon-like Peptide-1 Agonists, Antidepressants, dopamine reuptake inhibitors; opioid antagonists”. emedicine.medscape.com. Arhivat din original la 4 noiembrie 2016. Accesat în 2 noiembrie 2016.

nih.gov

ncbi.nlm.nih.gov

„Drug interventions for the treatment of obesity in children and adolescents”. The Cochrane Database of Systematic Reviews. 11 (11): CD012436. noiembrie 2016. doi:10.1002/14651858.CD012436. PMC 6472619 . PMID 27899001.
„Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians”. Annals of Internal Medicine. 142 (7): 525–531. aprilie 2005. doi:10.7326/0003-4819-142-7-200504050-00011. PMID 15809464.
„The obesity pipeline: current strategies in the development of anti-obesity drugs”. Nature Reviews. Drug Discovery. 5 (11): 919–931. noiembrie 2006. doi:10.1038/nrd2136. PMID 17080028.
„Use and abuse of appetite-suppressant drugs in the treatment of obesity”. Annals of Internal Medicine. 119 (7 Pt 2): 707–713. octombrie 1993. doi:10.7326/0003-4819-119-7_Part_2-199310011-00016. PMID 8363202.
„Effects of GLP-1 on appetite and weight”. Reviews in Endocrine & Metabolic Disorders. 15 (3): 181–187. septembrie 2014. doi:10.1007/s11154-014-9289-5. PMC 4119845 . PMID 24811133.
„Dinitrophenol and bioenergetics: an historical perspective”. Molecular and Cellular Biochemistry. 5 (1–2): 69–77. noiembrie 1974. doi:10.1007/BF01874175. PMID 4610359.
„The return of rainbow diet pills”. American Journal of Public Health. 102 (9): 1676–1686. septembrie 2012. doi:10.2105/AJPH.2012.300655. PMC 3482033 . PMID 22813089.
„Imported fenproporex-based diet pills from Brazil: a report of two cases”. Journal of General Internal Medicine. 24 (3): 430–433. martie 2009. doi:10.1007/s11606-008-0878-4. PMC 2642570 . PMID 19096898.
„Imported compounded diet pill use among Brazilian women immigrants in the United States”. Journal of Immigrant and Minority Health. 11 (3): 229–236. iunie 2009. doi:10.1007/s10903-007-9099-x. PMID 18066718.
„Dependence on the Brazilian diet pill: a case report”. The American Journal on Addictions. 19 (3): 291–292. mai 2010. doi:10.1111/j.1521-0391.2010.00034.x. PMID 20525038.
„Once-Weekly Semaglutide in Adults with Overweight or Obesity”. The New England Journal of Medicine. 384 (11): 989–1002. martie 2021. doi:10.1056/NEJMoa2032183. PMID 33567185.
„Phentermine/topiramate for the treatment of obesity”. The Annals of Pharmacotherapy. 47 (3): 340–349. martie 2013. doi:10.1345/aph.1R501. PMID 23482732.
„Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial”. Lancet. 376 (9741): 595–605. august 2010. doi:10.1016/S0140-6736(10)60888-4. PMID 20673995.
„Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study”. Lancet. 374 (9701): 1606–1616. noiembrie 2009. doi:10.1016/S0140-6736(09)61375-1. PMID 19853906.
„A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss”. Obesity. 27 (2): 205–216. februarie 2019. doi:10.1002/oby.22347. PMC 6587502 . PMID 30421844.
„Drug treatments for obesity: orlistat, sibutramine, and rimonabant”. Lancet. 369 (9555): 71–77. ianuarie 2007. doi:10.1016/S0140-6736(07)60033-6. PMID 17208644.
„Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes”. The New England Journal of Medicine. 385 (6): 503–515. august 2021. doi:10.1056/NEJMoa2107519. PMID 34170647.
„Tirzepatide Once Weekly for the Treatment of Obesity”. The New England Journal of Medicine. 387 (3): 205–216. iulie 2022. doi:10.1056/NEJMoa2206038. PMID 35658024 Verificați valoarea |pmid= (ajutor).
Digoxin
„Current and potential drugs for treatment of obesity”. Endocrine Reviews. 20 (6): 805–875. decembrie 1999. doi:10.1210/edrv.20.6.0383. PMID 10605627.
Siskind, Dan J.; Leung, Janni; Russell, Anthony W.; Wysoczanski, Daniel; Kisely, Steve (15 iunie 2016). Holscher, Christian, ed. „Metformin for clozapine associated obesity: a systematic review and meta-analysis”. PLOS ONE (în engleză). 11 (6): e0156208. Bibcode:2016PLoSO..1156208S. doi:10.1371/journal.pone.0156208. ISSN 1932-6203. PMC 4909277 . PMID 27304831.

win.niddk.nih.gov

„WIN – Publication – Prescription Medications for the Treatment of Obesity”. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). National Institutes of Health^⁠(d). Arhivat din original la 13 ianuarie 2009. Accesat în 14 ianuarie 2009.

poison.org

Is it Safe to Take Thyroid Hormones for Weight Loss?

ucl.ac.uk

discovery.ucl.ac.uk

„Once-Weekly Semaglutide in Adults with Overweight or Obesity”. The New England Journal of Medicine. 384 (11): 989–1002. martie 2021. doi:10.1056/NEJMoa2032183. PMID 33567185.

usu.edu

teacherlink.ed.usu.edu

„Diabetes Medications: Metformin” (PDF). Arhivat din original (PDF) la 8 iulie 2015. Accesat în 21 octombrie 2015.

web.archive.org

„WIN – Publication – Prescription Medications for the Treatment of Obesity”. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). National Institutes of Health^⁠(d). Arhivat din original la 13 ianuarie 2009. Accesat în 14 ianuarie 2009.
„www.fda.gov”. Food and Drug Administration. Arhivat din original la 18 ianuarie 2017. Accesat în 16 decembrie 2019.
„Evekeo Prescribing Information” (PDF). Arbor Pharmaceuticals LLC. aprilie 2014. pp. 1–2. Arhivat din original (PDF) la 4 martie 2016. Accesat în 11 august 2015.
„Obesity Medication: Gastrointestinal Agents, Other, CNS Stimulants, Anorexiants, Glucagon-like Peptide-1 Agonists, Antidepressants, dopamine reuptake inhibitors; opioid antagonists”. emedicine.medscape.com. Arhivat din original la 4 noiembrie 2016. Accesat în 2 noiembrie 2016.
„Diabetes Medications: Metformin” (PDF). Arhivat din original (PDF) la 8 iulie 2015. Accesat în 21 octombrie 2015.

wikidata.org

„WIN – Publication – Prescription Medications for the Treatment of Obesity”. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). National Institutes of Health^⁠(d). Arhivat din original la 13 ianuarie 2009. Accesat în 14 ianuarie 2009.

worldcat.org

Siskind, Dan J.; Leung, Janni; Russell, Anthony W.; Wysoczanski, Daniel; Kisely, Steve (15 iunie 2016). Holscher, Christian, ed. „Metformin for clozapine associated obesity: a systematic review and meta-analysis”. PLOS ONE (în engleză). 11 (6): e0156208. Bibcode:2016PLoSO..1156208S. doi:10.1371/journal.pone.0156208. ISSN 1932-6203. PMC 4909277 . PMID 27304831.